Breast cancer patients could be spared chemotherapy with new genetic test, study shows

By Kate Aubusson
Updated September 10 2016 - 11:08am, first published August 26 2016 - 9:26pm
A Mammaprint microarray showing the biopsy results of low risk (top) and high risk (bottom) breast cancer tumours. Photo: Supplied
A Mammaprint microarray showing the biopsy results of low risk (top) and high risk (bottom) breast cancer tumours. Photo: Supplied

It's a gruelling decision every breast cancer patient and their doctor must consider: do we need to start chemotherapy, or could we spare you the ravages of the toxic, yet potentially life-saving treatment?

Subscribe now for unlimited access.

$0/

(min cost $0)

or signup to continue reading

See subscription options

Get the latest Bega news in your inbox

Sign up for our newsletter to stay up to date.

We care about the protection of your data. Read our Privacy Policy.